|Articles|November 17, 2015
Parexel Adds Clinical Development Optimization
Advertisement
Parexel has enhanced its end-to-end clinical development services through its new Clinical Development Optimization process, which uses advanced technology to help expedite drug development through all four critical stages of clinical development – design, start-up, trial execution, and submission.
- Design: Protocol design optimization uses simulations to allow sponsors to identify and quantify the impact of trade-off decisions on program performance, timelines and cost.
- Start-up: Site start-up, Clinical Trial Management System, and electronic Trial Master File integrated applications provide efficient distribution, collaborative compilation and e-signing of site-level regulatory documents and contracts. Clinical Trial Supplies & Logistics handles supply chain challenges and optimizes supply levels.
- Execute: Intelligent technology from the PAREXEL Informatics product line helps predict and capture core operational and scientific data.
- Submit: Data aggregation aligned with commercial decision-making strategy can help ensure the right technology and operational support for an initial regulatory application, identification of future opportunities, and product lifecycle management.
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Generative AI Transforms Clinical Study Report Development
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5